TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTT

NCT05984511 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

234

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma
Hepatic Portal Vein Tumor Invasion
Tumor Thrombus

Interventions

PROCEDURE: I-125 Seeds Brachytherapy in PVTT
PROCEDURE: Transcatheter arterial chemoembolization
DRUG: Atezolizumab plus Bevacizumab

Sponsor

Third Affiliated Hospital, Sun Yat-Sen University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]